Anebulo Pharmaceuticals Inc. (ANEB) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Anebulo Pharmaceuticals I...

    NASDAQ: ANEB · Real-Time Price · USD
    2.31
    -0.09 (-3.75%)
    At close: Oct 03, 2025, 3:59 PM
    2.31
    0.00%
    After-hours: Oct 03, 2025, 04:52 PM EDT

    Anebulo Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    PE Ratio
    		 -5.74 -8.44 -5.02 -17.78 -5.26
    PEG Ratio
    		 0.26 0.26 -0.08 0.23 -0.00
    PS Ratio
    		 n/a n/a n/a n/a n/a
    PB Ratio
    		 4.18 18.15 5.56 8.06 7.44
    P/FCF Ratio
    		 -7.67 -8.55 -6.09 -22.33 -32.68
    P/OCF Ratio
    		 -7.67 -8.55 -6.09 -22.33 -32.68
    OCF/S Ratio
    		 n/a n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a n/a n/a n/a
    Quick Ratio
    		 53.36 13.46 21.04 28.39 82.71
    Current Ratio
    		 53.36 13.46 21.04 28.39 82.71
    Asset Turnover
    		 n/a n/a n/a n/a n/a
    Interest Coverage
    		 -24.14 -54.94 n/a -931.67 -307.13
    Return on Equity
    		 -0.73 -2.15 -1.11 -0.45 -1.41
    Return on Assets
    		 -0.7 -2.01 -1.01 -0.44 -1.4
    Return on Invested Capital
    		 -0.77 -2.18 -1.09 -0.45 -0.17
    Dividend Yield
    		 n/a n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a n/a

    Add to Watchlist